Arimidex, Anastrozole

Arimidex, Anastrozole Newswire (Page 3)

Comprehensive Real-Time News Feed for Arimidex, Anastrozole (generic). (Page 3)

Results 41 - 60 of 135 in Arimidex, Anastrozole (generic)

  1. One million women denied the 7p breast cancer drug that can halve...Read the original story w/Photo

    Sep 28, 2014 | Daily Mail

    More than a million women are denied pills that could halve their chance of developing breast cancer because of red tape, experts warn. They say those at greater risk should be offered a preventative treatment that costs as little as 7p a day.

    Comment?

  2. Schnuck's Offers Breast Cancer Medications for $9Read the original story w/Photo

    Sep 26, 2014 | WEHT

    Schnucks Pharmacy has introduced it's breast cancer treatment program. Patients can now pay up to 10 times less for four medications the company says are important to cancer care.They include Letrozole, Megestrol, Anastrozole and Tamoxifen.

    Comment?

  3. Schnucks adds 4 breast cancer drugs to discount programRead the original story w/Photo

    Sep 26, 2014 | Business Journal

    Schnuck Markets Inc. is expanding its discount drug program as part of a new women's wellness initiative, adding generic versions of four medicines most commonly prescribed to treat breast cancer.

    Comment?

  4. New 'designer proteins' in fight against Alzheimer's, cancerRead the original story w/Photo

    Sep 24, 2014 | Science Daily

    Scientists are lending Mother Nature a helping hand in fight against cancer and Alzheimer's with the development of a new, more effective way to make amino acids. The new 'designer proteins' can be used to make more effective drugs with fewer side effects, they report.

    Comment?

  5. Array BioPharma, Inc. Appoints As Chief Medical OfficerRead the original story

    Sep 15, 2014 | BioSpace

    11, 2014 /PRNewswire/ -- Array BioPharma Inc. , a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of , M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and operations across the Array portfolio, including binimetinib, a MEK inhibitor in Phase 3 trials for ovarian cancer and melanoma, and filanesib, a KSP inhibitor for multiple myeloma.

    Comment?

  6. Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical OfficerRead the original story

    Sep 12, 2014 | Sys-Con Media

    11, 2014 /PRNewswire/ -- Array BioPharma Inc. , a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of , M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and operations across the Array portfolio, including binimetinib, a MEK inhibitor in Phase 3 trials for ovarian cancer and melanoma, and filanesib, a KSP inhibitor for multiple myeloma.

    Comment?

  7. Getting Hypertension Medicine Delivered to Your DoorRead the original story

    Sep 7, 2014 | San Diego NewsCape

    Hypertension or high blood pressure is a common condition that affects nearly 1 in 3 Americans. In addition to following a healthy diet and lifestyle, many people living with the condition are prescribed daily medication to control their hypertension and heart failure and will need long-term access to this important class of medicine.

    Comment?

  8. Getting Hypertension Medicine Delivered to Your Door Is Convenient With AstraZeneca DirectRead the original story

    Sep 5, 2014 | Las Vegas Newstrip

    Hypertension or high blood pressure is a common condition that affects nearly 1 in 3 Americans. In addition to following a healthy diet and lifestyle, many people living with the condition are prescribed daily medication to control their hypertension and heart failure and will need long-term access to this important class of medicine.

    Comment?

  9. Pfizer Announces Submission of Palbociclib New Drug Application to the FDARead the original story

    Aug 18, 2014 | Drugs.com

    Pfizer Inc. today announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib.

    Comment?

  10. Claire optimistic over new cancer statisticsRead the original story w/Photo

    Aug 21, 2014 | Theboltonnews.co.uk

    A CANCER survivor has welcomed the news that death rates for some of the UK's most common cancers have fallen.

    Comment?

  11. Death rates in top four cancer killers fall by a third over 20 yearsRead the original story

    Aug 18, 2014 | PhysOrg Weblog

    Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 years according to the latest Cancer Research UK figures released today.

    Comment?

  12. Pfizer Announces Submission of Palbociclib New Drug Application to the FDARead the original story

    Aug 18, 2014 | Business Wire

    Pfizer Inc. today announced it has completed the submission of a New Drug Application to the United States Food and Drug Administration for palbociclib.

    Comment?

  13. Death rates in top four cancer killers fall by almost a quarter over 20 years in the North EastRead the original story w/Photo

    Aug 17, 2014 | Chronicle Live

    New figures released from Cancer Research UK show that less people are dying from breast, bowel, lung and prostate cancers Cancer death rates have fallen by almost a quarter in the North East in the last 20 years thanks to improved screening and treatment.

    Comment?

  14. Sharp rise in survival rates for most common cancersRead the original story w/Photo

    Aug 17, 2014 | Sunday Herald

    THE number of Scots surviving the four most common cancers has soared during the last 20 years due to earlier detection and better treatment, according to a leading medical charity.

    Comment?

  15. Chael Sonnen Admits 'I Knew What I Was Doing; I Tried to Game the System'Read the original story w/Photo

    Aug 14, 2014 | MMA Weekly

    For a fighter that ended his career with a 29-14-1 record, Chael Sonnen enjoyed a tremendous amount of success in the final years of his career.

    Comment?

  16. Chael Sonnen admits intent to cheat: 'I thought I could have my cake and eat it too'Read the original story w/Photo

    Aug 13, 2014 | BloodyElbow

    Retired UFC competitor Chael Sonnen went on Chris Jericho's "Talk is Jericho" podcast, where he revealed his willful intention to take performance enhancing drugs to better his career.

    Comment?

  17. Health: Zapping Away Side Effects of Breast Cancer TreatmentRead the original story w/Photo

    Jul 30, 2014 | CBS Local

    New help for breast cancer patients struggling with difficult side effects caused by drugs taken to prevent a recurrence.

    Comment?

  18. Wanderlei Silva believes Chael Sonnen fight may still eventually...Read the original story w/Photo

    Jul 29, 2014 | BloodyElbow

    UFC light-heavyweight competitor Wanderlei Silva is convinced that Chael Sonnen will return to the octagon once he finishes his suspension.

    Comment?

  19. New insight into alternative treatment options for postmenopausal...Read the original story w/Photo

    Jul 26, 2014 | Medical News Today

    It's no wonder that breast cancer ranks highest among women's health concerns. Over 235,000 cases of breast cancer are diagnosed annually in the United States, with almost 40,000 deaths attributable to the disease.

    Comment?

  20. Chael Sonnen Suspended For Two Years For Failed Drug TestsRead the original story

    Jul 23, 2014 | 411mania.com

    Chael Sonnen Suspended For Two Years For Failed Drug Tests Posted by Joseph Lee on 07.23.2014 He won't be fighting for a while... MMA Junkie reports that the Nevada State Athletic Commission has suspended Chael Sonnen for two years after he failed two drug tests for UFC 175.

    Comment?